Table 1 Characteristic of participants
Variables | Total N = 11,911 | MA(−)/AS(−) N = 4228 | MA(+)/AS(−) N = 1714 | MA(−)/AS(+) N = 3238 | MA(+)/AS(+) N = 2731 | P |
|---|---|---|---|---|---|---|
Age (years) | 52 ± 5.6 | 50 ± 4.7 | 50 ± 4.6 | 54 ± 5.8 | 53 ± 5.9 | 0.000 |
Male | 8105 (68.0%) | 2610 (61.7%) | 1320 (77.0%) | 2078 (64.2%) | 2097 (76.8%) | 0.000 |
SBP (mmHg) | 128 ± 17.2 | 118 ± 12.5 | 121 ± 13.1 | 134 ± 16.0 | 139 ± 17.4 | 0.000 |
DBP (mmHg) | 81 ± 12.0 | 76 ± 9.8 | 79 ± 10.3 | 85 ± 11.1 | 89 ± 12.3 | 0.000 |
WC (cm) | 86 ± 8.8 | 84 ± 9.9 | 86 ± 9.0 | 85 ± 8.3 | 88 ± 8.4 | 0.000 |
FBG (mmol/L) | 5.2 (4.8,5.8) | 5.1 (4.8,5.5) | 5.1 (4.8,5.7) | 5.3 (4.9,5.8) | 5.5 (5.0,6.4) | 0.000 |
TG (mmol/L) | 1.5 (1.1.2.3) | 1.4 (1.0,1.9) | 1.6 (1.1,2.3) | 1.6 (1.1,2.3) | 1.8 (1.2,2.7) | 0.000 |
HDL (mmol/L) | 1.5 ± 0.4 | 1.5 ± 0.4 | 1.4 ± 0.4 | 1.5 ± 0.4 | 1.4 ± 0.4 | 0.000 |
Cholesterol (mmol/L) | 5.3 ± 1.0 | 5.2 ± 0.9 | 5.1 ± 1.0 | 5.3 ± 1.0 | 5.3 ± 1.1 | 0.000 |
Uric acid (mmol/L) | 320 ± 92 | 304 ± 90 | 325 ± 88 | 321 ± 92 | 340 ± 95 | 0.000 |
Non-smoker | 6606 (55.5%) | 2529 (59.8%) | 833 (48.6%) | 1901 (58.7%) | 1343 (49.2%) | 0.000 |
Antihyper- tensive | 557 (4.7%) | 162 (3.8%) | 142 (8.3%) | 135 (4.2%) | 118 (4.3%) | 0.000 |
Antidiabetic | 365 (3.1%) | 55 (1.3%) | 45 (2.6%) | 107 (3.3%) | 158 (5.8%) | 0.000 |
History of CVD | 221 (1.9%) | 42 (1.0%) | 22 (1.3%) | 74 (2.3%) | 83 (3.0%) | 0.000 |